Hos raske frivillige, der fik 100 mg [14C] - mærket dasatinib, udgjorde uomdannet dasatinib 29% af den cirkulerende radioaktivitet i plasma.
In healthy subjects administered 100 mg of [14C]-labelled dasatinib, unchanged dasatinib represented 29% of circulating radioactivity in plasma.